Merck CEO Robert Davis joins ‘Mornings with Maria’ to discuss the new $1 billion biologics manufacturing facility slated to be built in Wilmington, Delaware, and bringing manufacturing back to the U.S.
A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the Food and Drug Administration (FDA).
The approval of the new injectable treatment, called Bravecto Quantum, was announced by the federal agency on Thursday.
It is the “first FDA-approved drug that protects dogs against fleas and ticks for 8 to 12 months,” according to the FDA.
RAHWAY, NEW JERSEY – FEBRUARY 05: Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. The company announced on Monday that it would buy the aqua business of Elanco Animal Health Incorporated for $1.3 billio (Spencer Platt/Getty Images /…




